News

Thu Oct 24, 2024
The Department of Bioengineering and Therapeutic Sciences (BTS) chair is leading a multidisciplinary team that will receive federal funding to prevent side effects before drugs go to clinical trials.
Tue Aug 6, 2024
The director of the UCSF Institute for Human Genetics (IHG) is being recognized for his lab’s work investigating gene regulatory elements––their relationship to human diversity and disease and their utilization for gene therapy.
Mon Jul 8, 2024
June 14, 2024, marked the 15-year collaboration of a Chinese course improving medical product development and regulation.
Tue May 21, 2024
The pioneering career of one of the School’s most influential faculty members was honored on his 87th birthday.
Tue Apr 30, 2024

Bhushan Kharbikar, PhD, a postdoctoral fellow in the laboratories of Professors Qizhi Tang, PhD, and Tejal Desai, PhD, has been awarded a prestigious JDRF Advanced Postdoctoral Fellowship. JDRF is the leading global organization funding type 1 diabetes (T1D) research. This JDRF fellowship is designed to attract qualified and promising...

Mon Apr 1, 2024
The Preclinical Design and Clinical Translation of TB Regimens (PReDicTR) Consortium has been awarded a $30.8M grant over five years to research the most effective treatment options for future clinical testing.
Mon Mar 18, 2024
School researchers netted $36.7M from 65 grants, fueling efforts spanning drug discovery, bioengineering, pharmacokinetics, clinical pharmacy, and more.
Thu Feb 1, 2024
The first program of its kind in the United States, the MS in AICD3 will enable its graduates to gain a competitive edge for some of the most desirable jobs in the biopharmaceutical industry and in academia.
Mon Nov 27, 2023

Su Guo, PhD, will lead a new center to increase collaboration between clinical, translational, and discovery science in teaching and research.